Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 4:14 pm Purchase | 2021-12-31 | 13G | GLOBAL BLOOD THERAPEUTICS INC GBT | Baker Bros. Advisors LP | 3,314,765 5.100% | 3,314,765 (New Position) | Filing History |
| 2022-02-14 4:14 pm Purchase | 2021-12-31 | 13G | AEROVATE THERAPEUTICS INC AVTE | Baker Bros. Advisors LP | 52,337 7.500% | 52,337 (New Position) | Filing History |
| 2022-02-14 4:13 pm Purchase | 2021-12-31 | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | Baker Bros. Advisors LP | 4,541,604 8.000% | 1,001,334 (+28.28%) | Filing History |
| 2022-02-14 4:13 pm Sale | 2021-12-31 | 13G | AMARIN CORP PLC SPONSORED ADR AMRN | Baker Bros. Advisors LP | 1,064,659 5.400% | -341,098 (-24.26%) | Filing History |
| 2022-02-14 4:13 pm Purchase | 2021-12-31 | 13G | ALTIMMUNE INC ALT | Baker Bros. Advisors LP | 1,941,604 4.800% | 57,153 (+3.03%) | Filing History |
| 2022-02-14 4:13 pm Purchase | 2021-12-31 | 13G | ALIGOS THERAPEUTICS INC ALGS | Baker Bros. Advisors LP | 83,056 5.300% | 83,056 (New Position) | Filing History |
| 2022-02-14 4:12 pm Purchase | 2021-12-31 | 13G | ACHILLES THERAPEUTICS PLC ACHL | Baker Bros. Advisors LP | 4,039,480 9.990% | 4,039,480 (New Position) | Filing History |
| 2022-02-10 5:03 pm Purchase | 2022-02-09 | 13D | AEGLEA BIOTHERAPEUTICS, INC. C AGLE | Baker Bros. Advisors LP | 201,779 9.900% | 5,731 (+2.92%) | Filing History |
| 2022-01-31 5:10 pm Purchase | 2022-01-27 | 13D | KODIAK SCIENCES INC KOD | Baker Bros. Advisors LP | 15,566,068 30.100% | 848,776 (+5.77%) | Filing History |
| 2021-12-16 5:23 pm Unchanged | 2021-12-14 | 13D | ENTRADA THERAPEUTICS INC TRDA | Baker Bros. Advisors LP | 4,704,419 15.100% | 0 (Unchanged) | Filing History |
| 2021-11-10 4:50 pm Purchase | 2021-11-02 | 13G | ENTRADA THERAPEUTICS INC TRDA | Baker Bros. Advisors LP | 4,704,419 15.100% | 4,704,419 (New Position) | Filing History |
| 2021-10-01 5:10 pm Purchase | 2021-09-29 | 13D | KODIAK SCIENCES INC KOD | Baker Bros. Advisors LP | 14,717,292 28.500% | 393,424 (+2.75%) | Filing History |